Martin Everett

2.6k total citations
28 papers, 2.0k citations indexed

About

Martin Everett is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Martin Everett has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Medicine, 15 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Martin Everett's work include Antibiotic Resistance in Bacteria (16 papers), Tuberculosis Research and Epidemiology (11 papers) and Bacterial biofilms and quorum sensing (8 papers). Martin Everett is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Tuberculosis Research and Epidemiology (11 papers) and Bacterial biofilms and quorum sensing (8 papers). Martin Everett collaborates with scholars based in United Kingdom, United States and Singapore. Martin Everett's co-authors include Yossef Av‐Gay, Laura J. V. Piddock, Vito Ricci, Yongfeng Jin, David T. Davies, Nicholas J. White, Tom Solomon, Ha Vinh, Nguyen Thi Tuyet Hoa and Christopher M. Parry and has published in prestigious journals such as Journal of Biological Chemistry, Accounts of Chemical Research and Clinical Infectious Diseases.

In The Last Decade

Martin Everett

28 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Everett United Kingdom	19	761	741	720	542	329	28	2.0k
Liliana Rodrigues Portugal	23	761 1.0×	763 1.0×	898 1.2×	664 1.2×	223 0.7×	43	1.9k
Gerald Larrouy‐Maumus United Kingdom	28	1.2k 1.5×	637 0.9×	677 0.9×	680 1.3×	197 0.6×	87	2.4k
Alexey Ruzin United States	28	995 1.3×	1.2k 1.6×	880 1.2×	399 0.7×	510 1.6×	44	2.7k
F.-J. Schmitz Germany	17	603 0.8×	990 1.3×	750 1.0×	329 0.6×	297 0.9×	37	2.1k
E. Sauvage Belgium	24	1.2k 1.5×	966 1.3×	446 0.6×	398 0.7×	451 1.4×	50	2.6k
John Pace United States	19	459 0.6×	307 0.4×	618 0.9×	239 0.4×	362 1.1×	30	1.7k
Eilidh Mowat United Kingdom	17	1.4k 1.9×	332 0.4×	1.6k 2.2×	743 1.4×	471 1.4×	25	3.2k
Suzanne Chamberland Canada	21	910 1.2×	1.3k 1.8×	334 0.5×	426 0.8×	691 2.1×	38	2.1k
Darren Abbanat United States	19	495 0.7×	821 1.1×	272 0.4×	294 0.5×	565 1.7×	42	1.7k
Mark C. Sulavik United States	22	906 1.2×	594 0.8×	405 0.6×	217 0.4×	210 0.6×	28	2.0k

Countries citing papers authored by Martin Everett

Since Specialization

Citations

This map shows the geographic impact of Martin Everett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Everett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Everett more than expected).

Fields of papers citing papers by Martin Everett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Everett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Everett. The network helps show where Martin Everett may publish in the future.

Co-authorship network of co-authors of Martin Everett

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Everett. A scholar is included among the top collaborators of Martin Everett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Everett. Martin Everett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zalacaín, Magdalena, Ian Morrissey, Stephen Hawser, et al.. (2024). Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 68(3). e0112023–e0112023. 6 indexed citations

Zalacaín, Magdalena, Carole A. Sable, Marlène Murris, et al.. (2023). Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients. Scientific Reports. 13(1). 14208–14208. 9 indexed citations

Everett, Martin, David T. Davies, Jérôme Castandet, et al.. (2023). Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models. ACS Infectious Diseases. 9(2). 270–282. 15 indexed citations

Cigana, Cristina, Jérôme Castandet, Serena Ranucci, et al.. (2021). Pseudomonas aeruginosa Elastase Contributes to the Establishment of Chronic Lung Colonization and Modulates the Immune Response in a Murine Model. Frontiers in Microbiology. 11. 620819–620819. 29 indexed citations

Everett, Martin & David T. Davies. (2021). Pseudomonas aeruginosa elastase (LasB) as a therapeutic target. Drug Discovery Today. 26(9). 2108–2123. 60 indexed citations

Davies, David T., Jérôme Castandet, Michael S. Bodnarchuk, et al.. (2021). Virtual Screening Approach to Identifying a Novel and Tractable Series ofPseudomonas aeruginosaElastase Inhibitors. ACS Medicinal Chemistry Letters. 12(2). 217–227. 11 indexed citations

Davies, David T. & Martin Everett. (2021). Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria. Accounts of Chemical Research. 54(9). 2055–2064. 27 indexed citations

Das, Shampa, Adam Johnson, Laura McEntee, et al.. (2020). Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 64(11). 14 indexed citations

Everett, Martin, Alicia Coelho, Jérôme Castandet, et al.. (2018). Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 62(5). 84 indexed citations

10.

Chopra, Ian, Christopher J. Schofield, Martin Everett, et al.. (2008). Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. The Lancet Infectious Diseases. 8(2). 133–139. 197 indexed citations

11.

Lim, Stephanie, Kah Fei Wan, Victor C. Yu, et al.. (2008). Interaction of kendomycin and semi-synthetic analogues with the anti-apoptotic protein Bcl-xl. Bioorganic & Medicinal Chemistry Letters. 18(21). 5771–5773. 21 indexed citations

12.

Wall, Michael D., Gavin A.C. Chung, Esperanza Herreros, et al.. (2007). Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth. Bioorganic & Medicinal Chemistry Letters. 17(10). 2740–2744. 19 indexed citations

13.

Waddell, Simon J., Gavin A.C. Chung, Kevin J. Gibson, et al.. (2005). Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv. Letters in Applied Microbiology. 40(3). 201–206. 39 indexed citations

14.

Kremer, Laurent, Lynn G. Dover, Caroline Morehouse, et al.. (2001). Galactan Biosynthesis in Mycobacterium tuberculosis. Journal of Biological Chemistry. 276(28). 26430–26440. 125 indexed citations

15.

Sampson, Samantha L., Pauline T. Lukey, Robin M. Warren, et al.. (2001). Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. Tuberculosis. 81(5-6). 305–317. 83 indexed citations

16.

Av‐Gay, Yossef & Martin Everett. (2000). The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. Trends in Microbiology. 8(5). 238–244. 311 indexed citations

17.

Payton, Mark A., et al.. (1999). Cloning and Characterization of Arylamine N -Acetyltransferase Genes from Mycobacterium smegmatis and Mycobacterium tuberculosis : Increased Expression Results in Isoniazid Resistance. Journal of Bacteriology. 181(4). 1343–1347. 107 indexed citations

18.

Wain, John, Nguyen Thi Tuyet Hoa, Nguyen Tran Chinh, et al.. (1997). Quinolone‐ResistantSalmonella typhiin Viet Nam: Molecular Basis of Resistance and Clinical Response to Treatment. Clinical Infectious Diseases. 25(6). 1404–1410. 240 indexed citations

19.

Pumbwe, Lilian, Martin Everett, Robert E. W. Hancock, & Laura J. V. Piddock. (1996). Role ofgyrAmutation and loss of OprF in the multiple antibiotic resistance phenotype ofPseudomonas aeruginosaG49. FEMS Microbiology Letters. 143(1). 25–28. 18 indexed citations

20.

Everett, Martin, Timothy R. Walsh, Gérald Guay, & Paul Bennett. (1995). GcvA, a LysR-type transcriptional regulator protein, activates expression of the cloned Citrobacter freundii ampC -lactamase gene in Escherichia coli: cross-talk between DNA-binding proteins. Microbiology. 141(2). 419–430. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact